Reckitt Benckiser Group plc Investors: Important Class Action Update

Author: Dylan Bailey Updated: 06-16-2025 05:57 AM

Reckitt Benckiser Group plc Class Action Overview

The Gross Law Firm is reaching out to investors of Reckitt Benckiser Group plc regarding a significant class action lawsuit. This announcement serves to inform shareholders of the critical deadlines and potential implications for those who purchased shares during the specified class period.

Class Period and Allegations

The class period for this lawsuit spans from January 13, 2021, to July 28, 2024. During this time, it is alleged that the company failed to disclose critical information concerning the risks associated with its cow's milk-based formula, Enfamil. Specifically, allegations claim that preterm infants faced increased risks of developing necrotizing enterocolitis (NEC) when consuming this product.

This failure to communicate important health risks could have significant repercussions for Reckitt's sales, as well as exposing the company to potential legal claims. Moreover, the misleading statements made by the Defendants regarding the company's business operations and future prospects may have misled investors.

Registration and Deadlines

Shareholders are encouraged to register for the class action lawsuit, especially those who acquired shares during the class period mentioned above. The lead plaintiff deadline is set for August 4, 2025. Registering does not mean that you must accept any lead plaintiff role; it simply allows you to participate in any potential recovery.

Next Steps for Interested Investors

Upon registration, shareholders will gain access to a portfolio monitoring application that provides regular updates on the case. It is crucial for shareholders not to wait, as the deadline for seeking lead plaintiff status approaches. Participation in the lawsuit comes at no cost, and investors can remain informed about their rights throughout the process.

About The Gross Law Firm

The Gross Law Firm is a well-known national class action law firm focused on protecting the rights of investors. The firm is dedicated to holding companies accountable for deceitful, fraudulent, and illegal business practices. Their commitment is to advocate for investors who have suffered losses due to misleading statements or omitted material information that artificially inflated the stock value.

By prioritizing responsible business practices and corporate citizenship, The Gross Law Firm seeks justice for all of its clients.

Frequently Asked Questions

What is the purpose of this class action lawsuit?

This class action lawsuit aims to address the allegations that Reckitt Benckiser Group plc misled investors about the risks associated with its product, Enfamil, and failed to disclose critical health information.

Who can participate in the lawsuit?

Any shareholder who purchased shares of Reckitt Benckiser Group plc during the class period from January 13, 2021, to July 28, 2024, is eligible to participate in this lawsuit.

What are the key deadlines for shareholders?

The main deadline for seeking lead plaintiff status is August 4, 2025. It's important for shareholders to register as soon as possible to secure their position in the class action.

What happens after registration?

Once registered, shareholders will receive updates through a portfolio monitoring software that keeps them informed about the case's progress and developments.

What does The Gross Law Firm do?

The Gross Law Firm represents investors who have been impacted by misleading corporate practices, working to recover losses and ensure accountability from companies.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.